Vanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb S SayaniDesignation :- Company Secretary and Compliance Officer Vanta Bioscience Ltd - 540729 - Announcement under Regulation 30 (LODR)-Resignation of Director
Resignation of Mr. S Venkata Rao as Whole Time Director and CEO of the Company Vanta Bioscience Ltd - 540729 - Unaudited Financial Results For The Half Year Ended 30.09.2020
Outcome of Board Meeting held on 13.11.2020 along with unaudited financial results for the half year ended 30.09.2020 Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Approving The Un-Audited Financial Statements For The Half Year Ended September 30, 2020 And Other Matters.
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020 ,inter alia, to consider and approve the Standalone and Consolidated un-audited Financial Statements of the Company for the half year ended September 30, 2020 and other matters Vanta Bioscience Ltd - 540729 - Shareholding for the Period Ended September 30, 2020
Vanta Bioscience Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here Vanta Bioscience Ltd - 540729 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For Half Year Ended September 30, 2020
Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for half year ended September 30, 2020 Vanta Bioscience Ltd - 540729 - Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For Half Year Ended September 30, 2020
Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for half year ended September 30, 2020 Vanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb SayaniDesignation :- Company Secretary and Compliance Officer Vanta Bioscience Ltd - 540729 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Vanta Bioscience Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Vanta Bioscience Ltd - 540729 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results, Scrutinizers Report and proceedings of 4th Annual General Meeting held on 30.09.2020